Chughtai Lab: Sputnik V Available for Commercial Use
Chughtai Lab will soon receive Russia’s Sputnik V Covid-19 vaccine which will be available for commercial sale, a company official revealed.
According to a company official, Chughtai Lab will soon receive Russia’s Sputnik V Covid-19 vaccine which will be available for commercial sale. The news spread fast online after the official tweeted on Sunday, February 14.
This will make Pakistan one of the first countries to market shots privately as it struggles to secure supplies.
Regardless of the concerns over reliability and higher prices, Islamabad agreed this week to allow the commercial import and sale of the Sputnik V vaccine without price caps. This is in contrast to most countries who are importing and administering vaccines through government bodies.
“We are told the first shipment is expected within the next week,” Chughtai Lab director Omar Chughtai told the press, adding it would be receiving several thousand doses of the Sputnik V. The news was also confirmed on Twitter.
At @ChughtaiLab we are expecting our first shipment of the #COVID vaccine insha Allah within the next 1-2 weeks.
The Sputnik V vaccine has been shown to be 91.6 % effective. Already authorized for use in Pakistan.
Working on appointment setting system. More details soon. pic.twitter.com/2kJUzgKvne
— Dr Omar Chughtai (@OmarChughtai) February 13, 2021
Former special assistant to the Prime Minister on health, Dr Zafar Mirza, while praising the government’s efforts to procure and distribute the free vaccine, said that avoiding a price cap for private sales of Sputnik V “will deepen inequality in society at a time when there is a need to have widespread coverage”.
The government launched a vaccination drive in February with 500,000 doses of the Sinopharm vaccine donated by ally China. However, besides the donated Chinese doses, Islamabad has not completed any deals to buy vaccines.
Sputnik V is one of four vaccines that has been approved for emergency use in Pakistan, in addition to those by China’s Sinopharm and CanSinoBio, and the AstraZeneca-Oxford University shot.
About Us:
Runway Pakistan is a complete solution provider for all your marketing communications related requirements. The ultimate hub of infotainment – Runway composes of all the key offerings – Monthly Print Magazine, Digital Magazine, Media Production, Creative Agency, PR Agency, and Marketing Consultancy that a brand needs to be seen, heard, and known!
Like and follow our Facebook page:
Runway Pakistan